文献速递鼻科睡眠呼吸障碍

尿白三烯E4作为慢性鼻窦炎伴哮喘和特应性诊断生物标志物的建立

Establishing Urinary Leukotriene E4 as a Diagnostic Biomarker for Chronic Rhinosinusitis with Comorbid Asthma and Atopy.
PubMed 文献 · Otolaryngol Head Neck Surg · 2019-08-27

本前瞻性病例对照研究纳入153例受试者,比较慢性鼻窦炎(CRS)患者与健康对照的尿白三烯E4(uLTE4)水平。uLTE4可作为CRS炎症状态的无创标志物,合并哮喘和特应性影响其水平。

要点

  • CRS患者uLTE4水平显著高于健康对照。
  • 合并哮喘的CRS患者uLTE4水平显著升高。
  • 无过敏和哮喘的CRS患者uLTE4与健康对照无显著差异。

核心结论

  • uLTE4是CRS炎症状态的无创标志物,合并哮喘和特应性可使其水平升高。

研究设计与样本

  • 前瞻性病例对照研究,纳入153例受试者(平均年龄47.3岁,女性47.1%),比较CRS患者与健康对照的uLTE4水平。

关键数值与推荐

  • uLTE4以尿肌酐校正,单位为pg/mg Cr。
  • CRS患者uLTE4参考值:合并哮喘者1597 pg/mg Cr;无过敏和哮喘者1142 pg/mg Cr。

临床怎么用

  • uLTE4可作为CRS炎症状态的无创评估指标,合并哮喘或特应性时解读需考虑其影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While urinary leukotriene E4 (uLTE4) is a validated biomarker for the cysteinyl leukotriene pathway, which is central to the pathophysiology of asthma, atopy, and chronic rhinosinusitis (CRS), the contributions of comorbid asthma and atopy to uLTE4 levels in various CRS subtypes have not been previously characterized. We sought to (1) identify reference values for uLTE4 in subjects with and without CRS and (2) determine how the presence of comorbid atopy and asthma affects uLTE4 levels in CRS. SETTING: Tertiary referral medical center. SUBJECTS AND METHODS: A prospective case-control study was conducted to compare uLTE4 levels between patients with CRS and healthy controls. Urinary LTE4 levels were measured by enzyme immunoassay and were adjusted for urinary creatinine concentrations (pg/mg Cr). Patients with CRS were stratified by the clinical comorbidities to determine normative uLTE4 values for patients with CRS with and without comorbid asthma or atopy. RESULTS: A total of 153 patients (mean age, 47.3; 47.1% female) were included in the study. Patients with CRS demonstrated significantly higher concentrations of uLTE4 than healthy controls (1652 vs 1065 pg/mg Cr, P = .032). Within the group of patients with CRS, comorbid asthma also individually correlated with elevated uLTE4 levels (1597 pg/mg Cr, P = .0098). Patients with CRS who did not have comorbid allergy and asthma, in contrast, did not have statistically higher uLTE4 levels than healthy controls (1142 pg/mg Cr, P = .61). CONCLUSION: Urinary LTE4 serves as a noninvasive measure of the inflammatory state in CRS. Comorbid asthma and atopy contribute to elevated uLTE4 levels in CRS.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Santarelli GD, Lam KK, Han JK, et al. Establishing Urinary Leukotriene E4 as a Diagnostic Biomarker for Chronic Rhinosinusitis with Comorbid Asthma and Atopy. Otolaryngol Head Neck Surg. 2019. PMID: 31453737. doi:10.1177/0194599819871700

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。